What features could LGC add to its oligonucleotide synthesis platform to enhance customization options for researchers?

Introduction

To enhance customization options for researchers on LGC's oligonucleotide synthesis platform, we need to identify key features that will improve the user experience and expand the platform's capabilities. I'll approach this by analyzing user segments, pain points, and potential solutions, keeping in mind the unique needs of researchers in this field.

Step 1

Clarifying Questions

• Looking at the product context, I'm thinking about the current state of LGC's platform. Could you provide more information about the existing customization options and their limitations?

Why it matters: This helps identify gaps in the current offering and areas for improvement. Expected answer: Limited options for sequence modifications, restrictions on oligo length, or limited bulk order capabilities. Impact on approach: Would focus on expanding specific customization features based on current limitations.

• Considering user behavior, I'm curious about the most common use cases for oligonucleotide synthesis among our researchers. What are the top 3-5 applications they're using our platform for?

Why it matters: Helps prioritize features that align with the most frequent use cases. Expected answer: PCR primers, gene synthesis, CRISPR guide RNAs, and DNA probes. Impact on approach: Would tailor customization options to support these specific applications.

• Regarding product lifecycle, where does LGC's platform stand in terms of market share and growth? Are we looking to expand our user base or increase engagement with existing users?

Why it matters: Determines whether to focus on attracting new users or enhancing value for current ones. Expected answer: Established player with steady growth, aiming to increase market share. Impact on approach: Would balance new features to attract users with improvements for existing customers.

• In terms of external factors, how has the competitive landscape evolved recently? Are there any emerging technologies or trends in oligonucleotide synthesis that we should be aware of?

Why it matters: Ensures our improvements are competitive and forward-looking. Expected answer: Increased demand for longer oligos, rise of AI-assisted design tools, and growing interest in modified nucleotides. Impact on approach: Would incorporate cutting-edge technologies and address emerging researcher needs.